Stéphane Bancel
Stéphane Bancel | |
|---|---|
| Born | 1972 or 1973 (age 51–52)[1] France |
| Education | CentraleSupélec University of Minnesota Harvard Business School |
| Occupation | Businessman |
| Known for | CEO and 9% owner of Moderna |
| Title | CEO, Moderna |
| Term | 2013– |
Stéphane Bancel (born 1972/1973) is a French billionaire businessman. He is the chief executive officer (CEO) and a 9% owner of Moderna, an American biotechnology company.
Early life
Bancel was born in France and earned master's degrees in engineering from CentraleSupélec of Paris-Saclay University (former École Centrale Paris) and the University of Minnesota.[1] He went on to earn an MBA from Harvard Business School.[3]
Career
Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium.[3] In 2007, he became CEO of French diagnostics company BioMérieux.[3]
In 2011, Bancel joined Moderna, becoming CEO. Stat news reported that Bancel led a highly secretive culture with little outside review of its science or research.[3]
Personal life
Bancel has two children.[4] In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.[1]
References
- ^ a b c Tognini, Giacomo (3 April 2020). "Moderna CEO Stéphane Bancel Becomes A Billionaire As Stock Jumps On Coronavirus Vaccine News". Forbes. Archived from the original on 3 April 2020. Retrieved 4 April 2020.
- ^ "Forbes profile: Stéphane Bancel". Forbes. Retrieved 2 December 2020.
- ^ a b c d Garade, Damien (13 September 2016). "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". Stat. Archived from the original on 16 November 2020. Retrieved 18 May 2020.
- ^ "Story Details - Alumni - Harvard Business School". www.alumni.hbs.edu. Retrieved 2 December 2020.
 | This French business–related biographical article is a stub. You can help Wikipedia by expanding it. |